Vimarsana
Biggest News Aggregation in the World

Johan Baeck News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johan Baeck. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johan Baeck Today - Breaking & Trending Today

Promontory Therapeutics Announces Early Phase 2 Clinical Trial Data From the National Cancer Institute, Demonstrating PT-112's Immune Activation in Thymic Epithelial Tumors - Vimarsana News

Promontory Therapeutics Announces Early Phase 2 Clinical Trial Data From the National Cancer Institute, Demonstrating PT-112's Immune Activation in Thymic Epithelial Tumors

/PRNewswire/ -- The National Cancer Institute (NCI), part of the National Institutes of Health, under formal collaboration with Promontory Therapeutics Inc., a...

Promontory Therapeutics Expands Clinical Trial for Prostate Cancer Treatment - Vimarsana News

Promontory Therapeutics Expands Clinical Trial for Prostate Cancer Treatment

By Daniella Parra Promontory Therapeutics, a clinical stage pharmaceutical company focused on oncology, said it treated its first four patients in France for late-stage metastatic castration-resistant prostate cancer (mCRPC). The study is being led by oncologist Dr. Karim Fizazi at Gustave Roussy and the Military Hospital (HIA) Bégin in Paris, the company said. The trial […]

Source: yahoo.com
Promontory Therapeutics Announces Preliminary Data from the National Cancer Institute Phase 2 Clinical Trial of PT-112 in Thymoma and Thymic Carcinoma at 2023 ASCO Annual Meeting - Vimarsana News

Promontory Therapeutics Announces Preliminary Data from the National Cancer Institute Phase 2 Clinical Trial of PT-112 in Thymoma and Thymic Carcinoma at 2023 ASCO Annual Meeting

/PRNewswire/ -- Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing small molecule immunotherapies in oncology, announces...

Promontory Therapeutics to Participate in Business Development Strategies Panel at the Sachs 9th Annual Immuno-Oncology Innovation Forum - Vimarsana News

Promontory Therapeutics to Participate in Business Development Strategies Panel at the Sachs 9th Annual Immuno-Oncology Innovation Forum

/PRNewswire/ -- Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing small molecule immunotherapies in oncology, will participate in...

BioSpace Movers & Shakers: Jeffrey Leiden, Don Hayden, Zentalis, Entera and More - Vimarsana News

BioSpace Movers & Shakers: Jeffrey Leiden, Don Hayden, Zentalis, Entera and More

Life sciences organizations and companies strengthen their leadership teams and boards with these Movers & Shakers.